Delivery Order SPE2DR25D1100-SPE2DR26FDA8Y
- Not listed
- The Defense Logistics Agency awarded a $1,009.49 delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Eucrisa 2% Ointment (60GM). This competitively awarded, firm fixed-price contract is classified as a non-set-aside award and is scheduled for completion by December 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,309.44 to AmerisourceBergen Drug Corp for Eucrisa 2% Ointment (60 grams) on October 28, 2025, with an ultimate completion date of October 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,545.62 to supply Eucrisa 2% Ointment in 100-gram quantities. This non-competitive, competitively awarded delivery order represents a firm fixed price contract with an ultimate completion date of June 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child order issued under a larger Indefinite Delivery Contract vehicle. This...
- This delivery order, valued at $1,538.37, awards AmerIsourceBergen Drug Corp the supply of Eucrisa 2% Ointment in 60-gram quantities under a Defense Logistics Agency (DLA) contract with a firm fixed price structure. The award was made on January 21, 2026, with an ultimate completion date of January 22, 2026, and carries no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, which serves as the corporate headquarters for...
- The Defense Logistics Agency awarded a delivery order valued at $1,956.74 to AmerisourceBergen Drug Corp for Eucrisa 2% Ointment (60gm), with an ultimate completion date of November 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Eucrisa 2% ointment. The contract has a ceiling value of $5,787.65 and a completion date of November 29, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,227.91 to AmerisourceBergen Drug Corp for EUCRISA 2% Ointment in 60-gram units. This firm fixed-price, non-set-aside contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,664.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 grams of EUCRISA 2% Ointment, with an ultimate completion date of January 7, 2026. This competitively awarded, non-set-aside contract was issued on January 6, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Eucrisa 2% ointment, a pharmaceutical product, with a ceiling value of $9,857.55 and a performance period through March 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, to provide a specialty branded pharmaceutical product - Eucrisa 2% Ointment 60GM. The award, valued at $7,349.06, has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDA8YDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,597.41 to Amerisourcebergen Drug Corp on January 21, 2026, for the supply of Eucrisa 2% Ointment in 60-gram quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 22, 2026, and represents a task order executed against a larger contract vehicle. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company operates as a subsidiary of Cencora, Inc., which does business as Amerisourcebergen and serves as the parent organization in the federal contracting relationship. This delivery order falls under Amerisourcebergen's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract award demonstrates the company's ongoing capability to meet competitive federal procurement requirements and deliver critical pharmaceutical products essential to Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 1/20/26 |